These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17020686)

  • 41. Effectiveness of subcutaneous low-dose erythropoietin in patients with chronic renal failure despite functional iron deficiency.
    Bedani PL; Cecchetti E; Gilli P
    Nephron; 1995; 71(4):459-60. PubMed ID: 8587628
    [No Abstract]   [Full Text] [Related]  

  • 42. The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin.
    Eschbach JW
    Kidney Int; 1989 Jan; 35(1):134-48. PubMed ID: 2651751
    [No Abstract]   [Full Text] [Related]  

  • 43. [Erythropoietin in 1991--pathophysiological and therapeutic aspects].
    Wiecek A
    Przegl Lek; 1992; 49(1-2):31-5. PubMed ID: 1455002
    [No Abstract]   [Full Text] [Related]  

  • 44. Impact of human recombinant erythropoietin on plasminogen activator inhibitor, and protein C and S activity.
    Steffensen G; Aunsholt NA
    Am J Nephrol; 1996; 16(5):453-4. PubMed ID: 8886186
    [No Abstract]   [Full Text] [Related]  

  • 45. [Recombinant human erythropoietin and chronic kidney failure: current situation and therapeutic implications].
    Romero González R; Torquet Escuder P
    Med Clin (Barc); 1990 Nov; 95(17):656-9. PubMed ID: 2089205
    [No Abstract]   [Full Text] [Related]  

  • 46. Erythropoietin escape in five CAPD patients.
    Williams P; Jones J
    Nephron; 1996; 73(2):354. PubMed ID: 8773387
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment of renal anemia with erythropoietin].
    Spustova V; Kovac A
    Bratisl Lek Listy; 1999 Aug; 100(8):432-8. PubMed ID: 10645031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of the anemia of chronic renal failure with recombinant human erythropoietin.
    Adamson JW; Eschbach JW
    Annu Rev Med; 1990; 41():349-60. PubMed ID: 2184735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of recombinant erythropoietin on electrolytes and nutrition in end-stage renal disease patients.
    Kaupke CJ; Vaziri ND
    Int J Artif Organs; 1993 Feb; 16(2):59-62. PubMed ID: 8486413
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect on hemoglobin F synthesis by erythropoietin in patients with anemia of end-stage renal disease maintained by chronic hemodialysis.
    Salvati F; Strippoli P; Barchetti M; Scatizzi A
    Nephron; 1992; 60(3):371. PubMed ID: 1373475
    [No Abstract]   [Full Text] [Related]  

  • 51. CPD: using evidence based clinical practice guidelines in the management of anaemia in patients with chronic renal failure.
    Price L; Osborne S
    Collegian; 2003 Jan; 10(1):35-7. PubMed ID: 15481510
    [No Abstract]   [Full Text] [Related]  

  • 52. [Advances in therapy of renal anemia: darbepoetin alfa].
    Schaefer R
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):955-7. PubMed ID: 12635460
    [No Abstract]   [Full Text] [Related]  

  • 53. Blood rheology in hemodialysis patients treated with recombinant human erythropoietin.
    Brunner R; Pollok M; Heidel M; Müller R; Degenhardt S; Baldamus CA
    Contrib Nephrol; 1989; 76():306-12; discussion 312-4. PubMed ID: 2582784
    [No Abstract]   [Full Text] [Related]  

  • 54. Hemoglobin levels, quality of life, and survival.
    Sadler JH; Meyer KB
    Nephrol News Issues; 2007 Aug; 21(9):42-3. PubMed ID: 17722853
    [No Abstract]   [Full Text] [Related]  

  • 55. Erythropoietin (r-HuEPO) for the treatment of anaemia in patients with multiple myeloma and end-stage renal failure.
    Svára F; Spicka I; Sulková S; Zabka J
    Nephrol Dial Transplant; 1995 Dec; 10(12):2374-5. PubMed ID: 8808252
    [No Abstract]   [Full Text] [Related]  

  • 56. Does correction of anemia with recombinant human erythropoietin accelerate the progression of renal insufficiency?
    Lim VS
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):26-7. PubMed ID: 2356366
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of recombinant human erythropoietin on the anemia of chronic renal failure.
    Urabe A; Takaku F; Mizoguchi H; Kubo K; Ota K; Shimizu N; Tanaka K; Mimura N; Nihei H; Koshikawa S
    Int J Cell Cloning; 1988 May; 6(3):179-91. PubMed ID: 3397592
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erythropoietin: a review.
    Ridley DM; Dawkins F; Perlin E
    J Natl Med Assoc; 1994 Feb; 86(2):129-35. PubMed ID: 8169988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of erythropoietin in Jehovah's Witness patients.
    Jim RT
    Hawaii Med J; 1990 Jun; 49(6):209. PubMed ID: 2397990
    [No Abstract]   [Full Text] [Related]  

  • 60. Monitoring erythropoietin therapy for anaemia of chronic renal failure by serum erythropoietin assays.
    Marsden JT; Sherwood RA; Hillis A; Peters TJ
    Ann Clin Biochem; 1993 Mar; 30 ( Pt 2)():205-6. PubMed ID: 8466156
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.